---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-22-019454"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T00:50:05.161691+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Precigen Q3 net loss $7.6M; cash $153.8M; retired $144M convertible notes

## Summary
- Net loss from continuing ops $7.6M ($0.04/sh) vs $26.3M loss; total revenues up $13.4M (>200%) YoY.
- Cash, equivalents, short-term investments and restricted cash totaled $153.8M as of Sep 30, 2022.
- Retired $144M of $200M convertible notes due July 2023 at a discount; realized $5.4M savings.
- Clinical: Phase 1 enrollment complete for PRGN-2012 in RRP; virtual R&D event Jan 2023; ASH presentations.
- Phase 1b expansion for PRGN-3006 at Mayo Clinic; first patient dosed; FDA clearance for repeat dosing.

## SEC filing metadata
- accession: 0000950103-22-019454
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000095010322019454/0000950103-22-019454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000095010322019454/dp184115_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-22-019454
- JSON: https://secwatch.observer/filing/0000950103-22-019454.json
- Plain text: https://secwatch.observer/filing/0000950103-22-019454.txt

## Key facts
- Earnings Releases
  PRECIGEN, INC. reported financial results for third quarter 2022.
  - Period: third quarter 2022
  - Result: reported results
  source text: precigen reports third quarter 2022 financial results and progress of clinical programs
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356090/000095010322019454/0000950103-22-019454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.